Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Short-term Effects of Methamphetamine Exposure on Residual Viral Transcription During Treated HIV Disease

NCT03825536 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT03825536
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03825536 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Short-term Effects of Methamphetamine Exposure on Residual Viral Transcription During Treated HIV Disease
Lead sponsor
University of California, San Francisco
Phase
Phase 4
Overall status
Completed
Start date
January 1, 2021
Completion date
January 11, 2023
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1-infection, methamphetamine-dependence